Sequential vidarabine infusion in the treatment of polyoma virus-associated acute haemorrhagic cystitis late after allogeneic bone marrow transplantation
Open Access
- 1 February 2000
- journal article
- case report
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 25 (3) , 319-320
- https://doi.org/10.1038/sj.bmt.1702129
Abstract
Late onset haemorrhagic cystitis (HC) occurs in 20–30% of allogeneic bone marrow transplant patients. Human polyomavirus BK (BKV) (or less frequently adenovirus) may be involved in the pathogenesis of viral HC and can represent a serious post-transplant complication. Diagnosis and treatment of viral HC can be difficult and has an uncertain outcome. We report the efficacy of sequential vidarabine in the treatment of a patient with severe BKV-associated HC, despite the delay in implementing therapy. Bone Marrow Transplantation (2000) 25, 319–320.Keywords
This publication has 4 references indexed in Scilit:
- Vidarabine therapy for virus-associated cystitis after allogeneic bone marrow transplantationBone Marrow Transplantation, 1997
- Association of BK Viruria with Hemorrhagic Cystitis in Recipients of Bone Marrow TransplantsNew England Journal of Medicine, 1986
- Adenovirus Infections in Patients Undergoing Bone-Marrow TransplantationNew England Journal of Medicine, 1985
- Role of Adenovirus Type 11 in Hemorrhagic Cystitis Secondary to ImmunosuppressionJournal of Urology, 1974